Skip to main content
Watch Insiders

Corporate insider profile

John Oyler Insider Trades

Latest reported as Chief Executive Officer of BeOne Medicines Ltd. (ONC).

Purchase filings
0
Reported companies
1
Net open-market value
-$297,222,243.54
Latest transaction
Aug 12, 2026

Affiliated corporations

Reported company relationships

ONCLatest reported

BeOne Medicines Ltd.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 12, 2026BeOne Medicines Ltd. (ONC)Chief Executive OfficerSale240,810$359.12$86,480,482
Jul 21, 2026BeOne Medicines Ltd. (ONC)Chief Executive OfficerSale109,713$315.28$34,590,852
Jul 17, 2026BeOne Medicines Ltd. (ONC)Chief Executive OfficerSale64,628$312.00$20,163,904
Jul 16, 2026BeOne Medicines Ltd. (ONC)Chief Executive OfficerSale283,154$315.56$89,351,595
Jul 14, 2026BeOne Medicines Ltd. (ONC)Chief Executive OfficerSale145,861$305.95$44,626,421
Jul 13, 2026BeOne Medicines Ltd. (ONC)Chief Executive OfficerSale60,218$303.18$18,256,809
Jun 23, 2026BeOne Medicines Ltd. (ONC)Chief Executive OfficerSale3,410$273.78$933,592
Jun 16, 2026BeOne Medicines Ltd. (ONC)Chief Executive OfficerSale3,693$265.55$980,686
Jun 11, 2026BeOne Medicines Ltd. (ONC)Chief Executive OfficerSale1,949$257.24$501,355
Jun 8, 2026BeOne Medicines Ltd. (ONC)Chief Executive OfficerSale4,940$270.56$1,336,548